Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Nanexa | NANEXA | Apr 18, 2024 | 0.63 | -1.26 |
NanoCap Group B | NANOCB | Apr 18, 2024 | 7.70 | -2.28 |
Nanoform Finland | NANOFS | Apr 18, 2024 | 30.00 | -3.23 |
Nanologica | NICA | Apr 18, 2024 | 5.72 | +0.35 |
NASDAQ OMX Small Cap Sweden GI | NOMXSCSEGI | Apr 18, 2024 | 4 030.70 | +0.08 |
NASDAQ OMX Small Cap Sweden PI | NOMXSCSE | Apr 18, 2024 | 2 528.94 | +0.07 |
Nattaro Labs | NATTA | Apr 18, 2024 | 0.63 | -0.79 |
Navigo Invest AB | NAVIGOSTAM | Apr 18, 2024 | 4.41 | -6.77 |
Navigo Invest Pref | NAVIGOPREF | Apr 18, 2024 | 105.50 | -0.47 |
NAXS | NAXS | Apr 18, 2024 | 65.20 | +0.62 |
NCAB Group | NCAB | Apr 18, 2024 | 62.45 | +0.48 |
NCC A | NCCA | Apr 18, 2024 | 126.00 | -2.33 |
NCC B | NCCB | Apr 18, 2024 | 127.40 | 0.00 |
Nederman Holding | NMAN | Apr 18, 2024 | 184.40 | +0.77 |
NEL | NELO | Apr 18, 2024 | 4.74 | +0.08 |
Nelly Group | NELLY | Apr 18, 2024 | 15.44 | -3.38 |
Neobo Fastigheter | NEOBO | Apr 18, 2024 | 18.01 | +1.18 |
NeoDynamics | NEOD | Apr 18, 2024 | 0.94 | +0.21 |
Neola Medical | NEOLA | Apr 18, 2024 | 2.42 | +24.10 |
Nepa | NEPA | Apr 18, 2024 | 28.50 | -1.72 |
Net Insight B | NETIB | Apr 18, 2024 | 5.99 | +2.57 |
Netel | NETEL | Apr 18, 2024 | 11.92 | -2.93 |
NetJobs Group | NJOB | Apr 18, 2024 | 0.32 | 0.00 |
New Nordic Healthbrands | NNH | Apr 18, 2024 | 20.20 | -2.88 |
New Wave B | NEWAB | Apr 18, 2024 | 109.80 | +1.01 |
Newbury Pharmaceuticals | NEWBRY | Apr 18, 2024 | 3.50 | 0.00 |
News55 | N55 | Apr 18, 2024 | 2.62 | -4.38 |
Nexam Chemical Holding | NEXAM | Apr 18, 2024 | 3.29 | -3.52 |
Nexar Group | NXAR | Apr 18, 2024 | 0.22 | +0.93 |
NextCell Pharma AB | NXTCL | Apr 18, 2024 | 2.63 | -7.39 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.